28 English-speaking jobs in Bergisch Gladbach

Note: Some links might not work outside the European Union

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 22

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Flink
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 22

Flink is your new go to online supermarket. Our goal is to revolutionize the world of grocery shopping forever. We offer a wide selection of more than 2,000 products all delivered to your door in 10 minutes. We source only the highest...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V.
  • Bergisch Gladbach, 51427
  • June 17

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V.
  • Bergisch Gladbach, 51427
  • June 17

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 16

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,500 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 16

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,000 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 16

Your role:As a Product Manager, you are responsible for the global marketing of our upcoming Sequencing Technologies portfolio in order to establish the brand for genomics in the field.Through regular market monitoring, analysis of market data/trends and direct interaction with key opinion...

  • Miltenyi Biotec B.V. & Co. KG
  • Bergisch Gladbach
  • June 15

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,000 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec BV and Co. KG
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 15

INsTRuCT is an Innovative Training Network (ITN) funded by the European Union Horizon 2020 Programme. The INsTRuCT Consortium is a research network of leading European scientists from academia and industry focused on fundamental research and clinical translation of myeloid regulatory cell (MRC)-based immunotherapies....

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 10

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,500 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 10

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,500 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 9

Progress prospers with inspiration and curiosity. For 30 years Miltenyi Biotec has been developing products and services that are used in basic research, translational research and cell therapy. Today we are a team of more than 3,000 scientists, physicians, engineers, marketers and...

  • Miltenyi Biotec
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 8

Reporting to the Capital Equipment Sales Manager, Flow Cytometry, BeNeLux, you will actively join an enthusiastic team dedicated to support customers. You will work in close collaboration with our Account Managers and will be jointly responsible for the sales growth of our...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, North Rhine-Westphalia
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, Nordrhein-Westfalen
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Bergisch Gladbach, Nordrhein-Westfalen
  • June 2

The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...

  • Miltenyi Biomedicine
  • Bergisch Gladbach, North Rhine-Westphalia
  • May 28

Miltenyi Biomedicine is a newly established international biopharmaceutical company that develops innovative cell and gene therapies. We are focused on bringing cancer treatments and regenerative therapies to patients. Our initial focus is on difficult to treat hematological cancers using CAR-T technology whilst exploring...